VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
OCULGEN
OCULGEN
In operation
Series B
Large Molecule Ophthalmic Innovation Drug Developer
Basic Information
OCULGEN Focuses on Innovative Macromolecular Ophthalmic Drugs for Fundus Diseases
--
Guangdong,China
15~50 people
August 24, 2022
--
cck@oculgen.com.cn
